Lord, Abbett & Co’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-466,668
| Closed | -$2.52M | – | 630 |
|
|
2020
Q4 | $2.52M | Sell |
466,668
-16,504
| -3% | -$88.9K | 0.01% | 623 |
|
|
2020
Q3 | $3.86M | Sell |
483,172
-24,349
| -5% | -$194K | 0.01% | 588 |
|
|
2020
Q2 | $5.08M | Buy |
+507,521
| New | +$5.08M | 0.02% | 568 |
|
|
2015
Q4 | – | Sell |
-111,094
| Closed | -$1.33M | – | 875 |
|
|
2015
Q3 | $1.33M | Sell |
111,094
-138,439
| -55% | -$1.66M | ﹤0.01% | 872 |
|
|
2015
Q2 | $4.57M | Buy |
+249,533
| New | +$4.57M | 0.01% | 789 |
|